TrumpRx is described as a direct-to-consumer prescription drug platform announced by President Trump, with partnerships reportedly including Pfizer and other pharma companies to offer discounted medications to U.S. consumers. Ownership and control of the TrumpRx platform appear to be tied to the Trump administration and its related initiatives, rather than a standalone private company. The latest reporting indicates the program is part of a broader effort to reduce drug costs through negotiated MFN-like pricing and direct-to- consumer access, but there is no indication of a separate, independent corporate owner for the TrumpRx brand itself as of the most recent updates. If you want the most current details on ownership or any corporate structuring, I can pull fresh sources.
